Jump to main content
Jump to site search

Issue 36, 2014
Previous Article Next Article

Structural characterization of form I of anhydrous rifampicin

Author affiliations

Abstract

Rifampicin is a first-line drug widely used in the treatment of tuberculosis both in the intensive and in the treatment phase. In this work we characterized the crystal structure of form I of anhydrous rifampicin mainly by using X-ray powder diffraction data combined with the Rietveld method. Other complementary techniques such as Fourier transform infrared spectroscopy and thermal analysis were also employed. It crystallized in a monoclinic crystal system with space group C2 and the following unit cell parameters: a = 25.8846(2) Å, b = 14.2965(2) Å, c = 14.2796(2) Å, β = 122.98(1)°, V = 4432.81(7) Å3, Z = 4, Z′ = 1 and ρcalc = 1.23310(2) g cm−3. A BFDH model was used to inspect the crystal morphology prediction, and great similarity with crystals observed on an optical microscope was found. The FTIR spectrum confirmed the results obtained by X-ray powder diffraction, which indicates that all the functional groups involved in H bonding are intramolecularly connected. This polymorphic form presented a thermal stability up to approximately 230 °C.

Graphical abstract: Structural characterization of form I of anhydrous rifampicin

Back to tab navigation

Supplementary files

Publication details

The article was received on 06 Jun 2014, accepted on 07 Jul 2014 and first published on 07 Jul 2014


Article type: Paper
DOI: 10.1039/C4CE01157K
Author version
available:
Download author version (PDF)
Citation: CrystEngComm, 2014,16, 8555-8562
  •   Request permissions

    Structural characterization of form I of anhydrous rifampicin

    A. L. Ibiapino, R. C. Seiceira, A. Pitaluga, A. C. Trindade and F. F. Ferreira, CrystEngComm, 2014, 16, 8555
    DOI: 10.1039/C4CE01157K

Search articles by author

Spotlight

Advertisements